The effect of medical innovation on the cost-effectiveness of Covid 19-related policies in the United States using a SIR model
Description
CONCLUSIONS: HTCI was the most cost effective and was well justified under any standard cost effectiveness threshold. The cost per QALY gained for vaccine development, either alone or in concert with other approaches, is well within the standard for